Home

Insights

Aarey Drugs & Pharmaceuticals Ltd P/E Ratio

Aarey Drugs & Pharmaceuticals Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.1 K

stocks traded

Image

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS

PE

31

Last updated : 20 May 10:08 AM

Key Highlights

    The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd is 31 as of 20 May 10:08 AM .a1#The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 10.3 on March 2019 to 15.9 on March 2023 . This represents a CAGR of 9.07% over 5 years. a1#The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 51.94 as of 18 May 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 67.58 crore on March 2019 to ₹ 60.09 crore on March 2023 . This represents a CAGR of -2.32% over 5 years. a1#The Revenue of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 119.7 crore to ₹ 76.77 crore over 7 quarters. This represents a CAGR of -22.42% a1#The EBITDA of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 1.75 crore to ₹ 3 crore over 7 quarters. This represents a CAGR of 36.07% a1#The Net Profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 0.8 crore to ₹ 1.91 crore over 7 quarters. This represents a CAGR of 64.42% a1#The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 3.57 % on March 2019 to 0 % on March 2023 . This represents a CAGR of -100.00% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1910.3
Mar '205.4
Mar '218.3
Mar '2216
Mar '2315.9

Fundamental Metrics

Market Cap

131 Cr

EPS

1.7

P/E Ratio (TTM) *

31.0

P/B Ratio (TTM) *

1.1

Day’s High

51.94

Day’s Low

51.91

DTE *

0.3

ROE *

2.8

52 Week High

68.0

52 Week Low

27.65

ROCE *

4.1

* All values are consolidated

* All values are consolidated

Image

Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS

PRICE

51.94

0.45(0.87%)

stock direction

Last updated : 18 May 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

Asset Value vs Market Value

Market Value

131

-0.5 X

Value addition

Asset Value

271

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

4 Cr

31.0 X

PE Ratio

Market Cap

₹130.76Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

4 Cr

31.0 X

PE Ratio

Market Cap

₹130.76Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Aarey Drugs & Pharmaceuticals Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Aarey Drugs & Pharmaceuticals Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Aarey Drugs & Pharmaceuticals Ltd's Share Price stands at 51.94. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-18T00:00:00 is 1.66. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 51.94/ 1.66= 31.03.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Aarey Drugs & Pharmaceuticals Ltd's stock is trading at approximately 31.03 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Aarey Drugs & Pharmaceuticals Ltd’s PE Ratio (BSE: AAREYDRUGS)

    The Price-to-Earnings (PE) ratio, used to assess Aarey Drugs & Pharmaceuticals Ltd's stock (BSE: AAREYDRUGS), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '1968
Mar '2031
Mar '2154
Mar '22105
Mar '2360

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '22120
Sep '2275
Dec '2263
Mar '22164
Jun '2352
Sep '2359
Dec '2377

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '222
Sep '223
Dec '222
Mar '223
Jun '232
Sep '233
Dec '233

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '221
Sep '222
Dec '221
Mar '220
Jun '231
Sep '231
Dec '232

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '194
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Aarey Drugs & Pharmaceuticals Ltd

About Aarey Drugs & Pharmaceuticals Ltd

    Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company. Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours. The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business. Apart from the bulk drug manufacturing activity, they also undertake importing & distributing of various industrial chemicals & solvents throughout the country. The company has their manufacturing unit located at Thane. The company's products include Methyl Nitro Imidazole, Metronidazole & Metronidazole Benzoate. Their pharmaceutical products are sourced from the authentic vendors to assure the quality and effectiveness. The pharmaceutical products offered by the company are in compliance with IP/ BP/ CP/ USP standards. They have their registered office is located at Thane and their corporate office is located at Mumbai. The company was established with the main object setting up manufacturing facilities for Bulk Drugs. In the year 1993, the company came with a public issue of 27,50,000 equity shares of Rs 10 each for cash at par aggregating to Rs 275 lakh. Also, the company shares were listed on the BSE, ASE & DSE. In May 2009, the company plant started to upgrade the existing plant into international standards. In June 2016, the Company commenced manufacturing of Mono Methyl Urea & Di Methyl Urea. In 2017-18, it added new products i.e. Erithromycin Derivates & Mafenamic Acid with capacity of 10 m.t. & 25 m.t. respectively in June' 2017. In 2018-19, it commenced manufacturing of products i.e. Ortho Para Nitro Anisole, 2-Bromomethyl-1,3 dioxolane, and Mefenamic Acid. It also commenced manufacturing products i.e.Metformin & Urasil.

Aarey Drugs & Pharmaceuticals Ltd News Hub

News

Aarey Drugs & Pharmaceuticals to consider Preferential Issue

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

20 Mar 2024 17:09

News

Aarey Drugs & Pharmaceuticals schedules board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

08 Feb 2024 10:22

News

Aarey Drugs & Pharmaceuticals to conduct EGM

Aarey Drugs & Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of th...

Read more

07 Dec 2023 12:09

News

Aarey Drugs & Pharmaceuticals to conduct board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

09 Nov 2023 11:04

News

Aarey Drugs & Pharmaceuticals to conduct board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

08 Aug 2023 17:05

News

Aarey Drugs & Pharmaceuticals to hold board meeting

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

08 Aug 2023 14:20

Product Composition by Percentage (Revenue)

FAQs for PE of Aarey Drugs & Pharmaceuticals Ltd

What is Aarey Drugs & Pharmaceuticals Ltd current share price?

The current market price of Aarey Drugs & Pharmaceuticals Ltd as of May 20, 2024 is ₹51.94.

What is Aarey Drugs & Pharmaceuticals Ltd's market cap?

Aarey Drugs & Pharmaceuticals Ltd's market capitalisation stood at ₹130 Cr as of May 20, 2024

What are Aarey Drugs & Pharmaceuticals Ltd's total net assets?

According to Aarey Drugs & Pharmaceuticals Ltd's most recent financial filings, the company's net assets total ₹270.6 Cr.

Is Aarey Drugs & Pharmaceuticals Ltd making a profit or loss?

Aarey Drugs & Pharmaceuticals Ltd's net Profit as of May 20, 2024 is close to ₹4 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199